Prognostic value of pheochromocytoma of the adrenal gland scaled score (PASS score) tests to separate benign from malignant neoplasms;La valeur pronostique du PASS score dans la distinction entre phéochromocytome bénin et malin

Tunisie Medicale

Volumn 91, Issue 3, 2013, Pages 209-215

  Mlika, Mona ^a,c   Kourda, Nadia ^a,c   Majdi Zorgati, Mohamed ^a,b,c   Bahri, Sonia ^a,b,c   Ben Ammar, Slim ^a,b,c   Zermani, Rachida ^a,c  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^c UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MALIGNANT NEOPLASTIC DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PASS SCORE; PATHOLOGY; PHEOCHROMOCYTOMA; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TUMOR DIFFERENTIATION;

ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY;

EID: 84877945016     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Poll H. Die vergleichende Entwicklung der nebennierensysteme. In: Hertwig O, ed. Handbuch der Entwicklungsgeschichte des Menschen und der Wirbeltiere. Jena: Gustave Fischer, 1905:443-8.
2. Samaan NA, Hickey RC, Shutts PE. Diagnosis, localization and management of pheochromocytoma: pitfalls and follow up in 41 patients. Cancer 1988;62:2451-60.
3. Thompson LDR, Young WF, Kawashima A, Komminoth P, Tischler AS. Malignant adrenal pheochromocytoma. In: DeLellis RA, Lioyd RV, Heitz PU, Eng C.World Health Organization Classification of tumours: Tumours of endocrine organs. IARC Press Lyon, 2004:147-151.
4. Frankel F. Ein Fall von doppelseitigem, vollig latent verlaufenen Nebennierentumor und gleichzeitiger Nephritis mit Veranderungen am Circulationsapparat und Retinitis. Arch Pathol Anat Physiol Klin Med 1886;103:244-63.
5. Hartmut PH, Neurmann M, Vortmeyer A, et al. Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med 2007;27:1311-15.
6. Koch CA, Vortmeyer AO, Huang SC, Alesci S, Zhuang Z, Pacak K. Genetic aspects of pheochromocytoma. Endocr Regul 2001;35:43-52.
7. Meyer-Rochow G, Smith JM, Richardson AL, et al. Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma. J Surg Res 2009;3:1-8.
8. Neumann HP, Bausch B, Mc Whinney SR, et al. Germ-line mutations in, nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459.
9. Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812
10. Qin Y, Yao L, King E, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nature genetics 2010;42:229-35.
11. Medeiros LJ, Wolf BC, Balgoh K, Federman M. Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. Hum Pathol 1985;16:580-9
12. Melicow MM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Prebyterian Medical center, 1926-1976. Cancer 1977;40:1987-99.
13. Mirallié E, Cariou B, Kraeber-Bodéré F. bilateral pheochromocytoma. Genetics and treatment. Ann Chir 2005; 130:273-76
14. Scott HWJ, Reynolds V, Green N, et al. Clinical experience with malignant pheochromocytomas. Surg Gynecol Obstet 1982;154:801-18.
15. Opocher G, Schiavi F, Cicala MV, et al. Genetics of adrenal tumors. Minerva Endocrinol 2009;34:107-21.
16. Thompson LDR. Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms. Am J Surg Pathol 2002;26:551-66
17. Modlin IM, farndon JR, Shepherd A, et al. Pheochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. Br J Surg 1979;66:456-65.
18. Orchard T, Grant CS, Van Heerden JA, Weaver A. Pheochromocytoma: continuing evolution of surgical therapy. Surgery 1993;114:1153-9.
19. Pommier RF, Vetto JT, Billingsly K, Woltering EA, Brennan MF. Comparison of adrenal and extra adrenal pheochromocytomas. Surgery 1993;114:1160-6.
20. Samaan NA, Hickey RC, Shutts PE. Diagnosis, localization, and management of pheochromocytoma: pitfalls and follow-up in 41 patients. Cancer 1988;62:2451-60.
21. Scopsi L, Castellani MR, Gullo M, et al. Malignant pheochromocytoma in multiple endocrine neoplasia type 2b syndrome: case report and review of the literature. Tumori 1996;82:480-4.
22. Westfried M, Mandel D, Alderete MN, Groopman J, Minkowitz S. Sipple's syndrome with a malignant pheochromocytoma presenting as a pericardial effusion. Cardiology 1978;63:305-11.
23. Gao B, Meng F, Bian W, et al. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas. Urology 2006;68:282-6.
24. Amar L, Baudin E, Burnichon N, et al. Succinate Dehydrogenase B Gene Mutations Predict Survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 2007;92:3822-28
25. Scott HWJ, Reynolds V, Green N et al. Clinical experience with malignant pheochromocytoma. Surg Gynecol Obstet 1982;154:801-18.
26. Bornstein SR, Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma: Increasing importance for clinical decision making. Ann N Y Acad Sci 2006;1073:94.
27. Van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and pheochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10:764-71.
28. Burnichon N, Rohmer V, Amar L, et al. The succinate dehydrogenase genetic testing in a large series of patients with paragangliomas. J Clin Endocrinol Metab 2009;94:2817-27.